Why the study?
Does baseline obesity and elevated CRP increase the risk of depressive symptoms over 4 years in older adults?
Does baseline obesity and elevated CRP increase the risk of depressive symptoms over 4 years in older adults?
Chronic inflammation, as measured by CRP, mediates approximately 20% of the longitudinal association between obesity and the development of depressive symptoms in older adults.
Supports CRP mediation of obesity-depression link in older adults; hypothesis-generating and requires randomized confirmation before clinical translation.
OBJECTIVE: Obesity has been shown to produce a state of systematic low-grade inflammation that may have detrimental neuropsychiatric effects. DESIGN AND METHODS: Longitudinal associations between obesity, inflammation, and depressive symptoms amongst a cohort of older English adults over 4 years of follow-up were examined. Participants were 3,891 obese and nonobese people drawn from the English longitudinal study of ageing (ELSA) [aged 64.9 (SD = 8.8) years, 44.6% men]. Depressive symptoms were assessed at baseline and after 4 years of follow-up using the eight-item center for epidemiological studies-depression scale (CES-D). RESULTS: Approximately 26.3% (N = 1,025) of the sample were categorized as obese at baseline. Obesity at baseline was associated with elevated levels of depressive symptoms at follow-up (P < 0.001), in analyses that adjusted for depression levels at baseline and sociodemographic and background variables including the prevalence of permanent illness/disability, alcohol consumption, sedentary behavior, and smoking. In addition, C-reactive protein (CRP) concentrations at baseline were independently associated with CES-D depression scores at follow-up (P = 0.008) in fully adjusted analyses. Subsequent mediation analyses revealed that CRP levels explained ∼20% of the obesity-related longitudinal change in depression scores. CONCLUSION: These data suggest that chronic inflammation may be a key determinant of depressive symptoms in obesity.
No takes yet. Share an insight, caveat, or question.
Michael Daly (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: